In recent years, there have been multiple breakthroughs in our understanding of lung cancer
biology. Despite significant advances in molecular targeted therapies, DNA-damaging …

Tumor response assessment has been a foundation for advances in cancer therapy. Recent
discoveries of effective targeted therapy for specific genomic abnormalities in lung cancer …

Background and purpose Radiomics provides opportunities to quantify the tumor phenotype
non-invasively by applying a large number of quantitative imaging features. This study …

Background and purpose Radiomics can quantify tumor phenotype characteristics non-
invasively by applying advanced imaging feature algorithms. In this study we assessed if pre …

PURPOSE: To analyze the long-term survival and tumor control outcomes after stereotactic
body radiotherapy (SBRT) for metastases limited in number and extent. METHODS AND …

Combining radiotherapy with immune checkpoint blockade may offer considerable
therapeutic impact if the immunosuppressive nature of the tumor microenvironment (TME) …

Introduction Tumor size is a known prognostic factor for early stage non–small-cell lung
cancer (NSCLC), but its significance in node-positive and locally invasive NSCLC has not …

Context.—The causes of death for patients with lung cancer are inadequately described.
Objective.—To categorize the immediate and contributing causes of death for patients with …

PURPOSE: Whole-pelvis (WP) concurrent chemoradiation (CCRT) is the standard bladder
preserving option for patients with invasive bladder cancer. The standard practice is to treat …

Purpose To examine the correlations between uni-dimensional RECIST and volumetric
measurements in patients with lung adenocarcinoma and to assess their association with …